These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 12589936)
1. Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines. Blanchère M; Saunier E; Mestayer C; Broshuis M; Mowszowicz I J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):297-304. PubMed ID: 12589936 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of transforming growth factor beta on human prostate cancer cells in vitro. Wilding G; Zugmeier G; Knabbe C; Flanders K; Gelmann E Mol Cell Endocrinol; 1989 Mar; 62(1):79-87. PubMed ID: 2545487 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells. Evangelou A; Jindal SK; Brown TJ; Letarte M Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107 [TBL] [Abstract][Full Text] [Related]
4. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP. Kim IY; Kim JH; Zelner DJ; Ahn HJ; Sensibar JA; Lee C Endocrinology; 1996 Mar; 137(3):991-9. PubMed ID: 8603613 [TBL] [Abstract][Full Text] [Related]
6. Role of prostatic basal cells in the regulation and suppression of human prostate cancer cells. Miniati DN; Chang Y; Shu WP; Peehl DM; Liu BC Cancer Lett; 1996 Jul; 104(2):137-44. PubMed ID: 8665481 [TBL] [Abstract][Full Text] [Related]
7. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone. Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651 [TBL] [Abstract][Full Text] [Related]
8. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. Sakko AJ; Ricciardelli C; Mayne K; Tilley WD; Lebaron RG; Horsfall DJ Cancer Res; 2001 Feb; 61(3):926-30. PubMed ID: 11221884 [TBL] [Abstract][Full Text] [Related]
9. Hormonal regulation of transforming growth factor beta-2 expression in human prostate cancer. Knabbe C; Klein H; Zugmaier G; Voigt KD J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):137-42. PubMed ID: 8274428 [TBL] [Abstract][Full Text] [Related]
10. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517 [TBL] [Abstract][Full Text] [Related]
11. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells. Seth D; Shaw K; Jazayeri J; Leedman PJ Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641 [TBL] [Abstract][Full Text] [Related]
12. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP. Kim IY; Zelner DJ; Lee C Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523 [TBL] [Abstract][Full Text] [Related]
13. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB. Barrett CS; Millena AC; Khan SA Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Fujiwara M; Muragaki Y; Ooshima A Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line. Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159 [TBL] [Abstract][Full Text] [Related]
16. Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells. Bruckheimer EM; Kyprianou N Endocrinology; 2001 Jun; 142(6):2419-26. PubMed ID: 11356690 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Guo Y; Kyprianou N Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855 [TBL] [Abstract][Full Text] [Related]
18. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. van der Poel HG Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107 [TBL] [Abstract][Full Text] [Related]
19. Androgen-independent prostate cancer DU145 cells suppress androgen-dependent growth of prostate stromal cells through production of inhibitory factors for androgen responsiveness. Minamiguchi K; Kawada M; Someno T; Ishizuka M Biochem Biophys Res Commun; 2003 Jul; 306(3):629-36. PubMed ID: 12810065 [TBL] [Abstract][Full Text] [Related]
20. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway. Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]